PubMed

Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype.

Rodrigo WW, Block OK, Lane C, Sukupolvi-Petty S, Goncalvez AP, Johnson S, Diamond MS, Lai CJ, Rose RC, Jin X, Schlesinger JJ.

Virology. 2009 Nov 25;394(2):175-82. Epub 2009 Oct 14.PMID: 19833371 [PubMed - in process]Related articles

Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.

Arévalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X.

J Med Virol. 2009 Mar;81(3):519-28.PMID: 19152413 [PubMed - indexed for MEDLINE]Related articles

An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells.

Shanaka WW, Rodrigo I, Alcena DC, Rose RC, Jin X, Schlesinger JJ.

Am J Trop Med Hyg. 2009 Jan;80(1):61-5.PMID: 19141841 [PubMed - indexed for MEDLINE]Related articles

Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2.

Rodrigo WW, Alcena DC, Kou Z, Kochel TJ, Porter KR, Comach G, Rose RC, Jin X, Schlesinger JJ.

Clin Vaccine Immunol. 2009 Feb;16(2):285-7. Epub 2008 Nov 26.PMID: 19038781 [PubMed - indexed for MEDLINE]Related articlesFree article

Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

Sapinoro R, Volcy K, Rodrigo WW, Schlesinger JJ, Dewhurst S.

Virology. 2008 Apr 10;373(2):274-86. Epub 2008 Jan 14.PMID: 18191979 [PubMed - indexed for MEDLINE]Related articlesFree article

Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.

Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, Jin X.

J Med Virol. 2008 Jan;80(1):134-46.PMID: 18041019 [PubMed - indexed for MEDLINE]Related articles

Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro.

Blackley S, Kou Z, Chen H, Quinn M, Rose RC, Schlesinger JJ, Coppage M, Jin X.

J Virol. 2007 Dec;81(24):13325-34. Epub 2007 Oct 10.PMID: 17928355 [PubMed - indexed for MEDLINE]Related articlesFree article

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.PMID: 17881453 [PubMed - indexed for MEDLINE]Related articlesFree article

Flavivirus nonstructural protein NS1: complementary surprises.

Schlesinger JJ.

Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18879-80. Epub 2006 Dec 4. No abstract available. PMID: 17146046 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).

Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ.

J Virol. 2006 Oct;80(20):10128-38.PMID: 17005690 [PubMed - indexed for MEDLINE]Related articlesFree article

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.

Chambers TJ, Liang Y, Droll DA, Schlesinger JJ, Davidson AD, Wright PJ, Jiang X.

J Virol. 2003 Mar;77(6):3655-68.PMID: 12610141 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.

Schlesinger JJ, Chapman SE.

Virology. 1999 Jul 20;260(1):84-8.PMID: 10405359 [PubMed - indexed for MEDLINE]Related articles

Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.

Ryman KD, Ledger TN, Weir RC, Schlesinger JJ, Barrett AD.

J Gen Virol. 1997 Jun;78 ( Pt 6):1353-6.PMID: 9191929 [PubMed - indexed for MEDLINE]Related articlesFree article

Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.

Schlesinger JJ, Chapman S, Nestorowicz A, Rice CM, Ginocchio TE, Chambers TJ.

J Gen Virol. 1996 Jun;77 ( Pt 6):1277-85.PMID: 8683217 [PubMed - indexed for MEDLINE]Related articlesFree article

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.

Schlesinger JJ, Chapman S.

J Gen Virol. 1995 Jan;76 ( Pt 1):217-20.PMID: 7844536 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.

Eckels KH, Dubois DR, Summers PL, Schlesinger JJ, Shelly M, Cohen S, Zhang YM, Lai CJ, Kurane I, Rothman A, et al.

Am J Trop Med Hyg. 1994 Apr;50(4):472-8.PMID: 8166355 [PubMed - indexed for MEDLINE]Related articles

The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.

Schlesinger JJ, Foltzer M, Chapman S.

Virology. 1993 Jan;192(1):132-41.PMID: 8517015 [PubMed - indexed for MEDLINE]Related articles

Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.

Megret F, Hugnot JP, Falconar A, Gentry MK, Morens DM, Murray JM, Schlesinger JJ, Wright PJ, Young P, Van Regenmortel MH, et al.

Virology. 1992 Apr;187(2):480-91.PMID: 1372140 [PubMed - indexed for MEDLINE]Related articles

New approaches to flavivirus vaccine development.

Schlesinger JJ, Putnak JR, Eckels KH.

Biotechnology. 1992;20:289-307. Review. No abstract available. PMID: 1318137 [PubMed - indexed for MEDLINE]Related articles

Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.

Deubel V, Bordier M, Megret F, Gentry MK, Schlesinger JJ, Girard M.

Virology. 1991 Jan;180(1):442-7.PMID: 1984665 [PubMed - indexed for MEDLINE]Related articles

Attenuation of wild-type yellow fever virus by passage in HeLa cells.

Barrett AD, Monath TP, Cropp CB, Adkins JA, Ledger TN, Gould EA, Schlesinger JJ, Kinney RM, Trent DW.

J Gen Virol. 1990 Oct;71 ( Pt 10):2301-6.PMID: 2230735 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.

Falgout B, Bray M, Schlesinger JJ, Lai CJ.

J Virol. 1990 Sep;64(9):4356-63.PMID: 2143542 [PubMed - indexed for MEDLINE]Related articlesFree article

Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.

Putnak JR, Schlesinger JJ.

J Gen Virol. 1990 Aug;71 ( Pt 8):1697-702.PMID: 2144016 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunogenicity of a purified fragment of 17D yellow fever envelope protein.

Brandriss MW, Schlesinger JJ, Walsh EE.

J Infect Dis. 1990 Jun;161(6):1134-9.PMID: 1693159 [PubMed - indexed for MEDLINE]Related articles

Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody.

Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE.

J Gen Virol. 1990 Mar;71 ( Pt 3):593-9.PMID: 2138210 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.

Walsh EE, Hall CB, Schlesinger JJ, Brandriss MW, Hildreth S, Paradiso P.

J Gen Virol. 1989 Nov;70 ( Pt 11):2953-61.PMID: 2479715 [PubMed - indexed for MEDLINE]Related articlesFree article

Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.

Henchal EA, Henchal LS, Schlesinger JJ.

J Gen Virol. 1988 Aug;69 ( Pt 8):2101-7.PMID: 3404125 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospects for a virus non-structural protein as a subunit vaccine.

Gibson CA, Schlesinger JJ, Barrett AD.

Vaccine. 1988 Feb;6(1):7-9. Review.PMID: 3281388 [PubMed - indexed for MEDLINE]Related articles

Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).

Lobigs M, Dalgarno L, Schlesinger JJ, Weir RC.

Virology. 1987 Dec;161(2):474-8.PMID: 2446422 [PubMed - indexed for MEDLINE]Related articles

Immunological differences between the envelope glycoproteins of two strains of human respiratory syncytial virus.

Walsh EE, Brandriss MW, Schlesinger JJ.

J Gen Virol. 1987 Aug;68 ( Pt 8):2169-76.PMID: 3302101 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.

Walsh EE, Hall CB, Briselli M, Brandriss MW, Schlesinger JJ.

J Infect Dis. 1987 Jun;155(6):1198-204.PMID: 3553346 [PubMed - indexed for MEDLINE]Related articles

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

Schlesinger JJ, Brandriss MW, Walsh EE.

J Gen Virol. 1987 Mar;68 ( Pt 3):853-7.PMID: 3819700 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative immunochemical and biological analysis of African and South American yellow fever viruses.

Deubel V, Schlesinger JJ, Digoutte JP, Girard M.

Arch Virol. 1987;94(3-4):331-8.PMID: 2437890 [PubMed - indexed for MEDLINE]Related articles

Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.

Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP.

J Virol. 1986 Dec;60(3):1153-5.PMID: 3783816 [PubMed - indexed for MEDLINE]Related articlesFree article

Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses.

Rice CM, Aebersold R, Teplow DB, Pata J, Bell JR, Vorndam AV, Trent DW, Brandriss MW, Schlesinger JJ, Strauss JH.

Virology. 1986 May;151(1):1-9.PMID: 3008425 [PubMed - indexed for MEDLINE]Related articles

Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies.

Walsh EE, Cote PJ, Fernie BF, Schlesinger JJ, Brandriss MW.

J Gen Virol. 1986 Mar;67 ( Pt 3):505-13.PMID: 2419491 [PubMed - indexed for MEDLINE]Related articlesFree article

Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.

Brandriss MW, Schlesinger JJ, Walsh EE, Briselli M.

J Gen Virol. 1986 Feb;67 ( Pt 2):229-34.PMID: 3944585 [PubMed - indexed for MEDLINE]Related articlesFree article

Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens.

Monath TP, Hill LJ, Brown NV, Cropp CB, Schlesinger JJ, Saluzzo JF, Wands JR.

J Clin Microbiol. 1986 Jan;23(1):129-34.PMID: 3700596 [PubMed - indexed for MEDLINE]Related articlesFree article

Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.

Schlesinger JJ, Brandriss MW, Walsh EE.

J Immunol. 1985 Oct;135(4):2805-9.PMID: 4031501 [PubMed - indexed for MEDLINE]Related articles

Homogeneity among Senegalese strains of yellow fever virus.

Deubel V, Pailliez JP, Cornet M, Schlesinger JJ, Diop M, Diop A, Digoutte JP, Girard M.

Am J Trop Med Hyg. 1985 Sep;34(5):976-83.PMID: 4037185 [PubMed - indexed for MEDLINE]Related articles

Purification and characterization of the respiratory syncytial virus fusion protein.

Walsh EE, Brandriss MW, Schlesinger JJ.

J Gen Virol. 1985 Mar;66 ( Pt 3):409-15.PMID: 3838336 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.

Schlesinger JJ, Walsh EE, Brandriss MW.

J Gen Virol. 1984 Oct;65 ( Pt 10):1637-44.PMID: 6208313 [PubMed - indexed for MEDLINE]Related articlesFree article

Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.

Monath TP, Schlesinger JJ, Brandriss MW, Cropp CB, Prange WC.

Am J Trop Med Hyg. 1984 Jul;33(4):695-8.PMID: 6206738 [PubMed - indexed for MEDLINE]Related articles

Antibody-mediated infection of P388D1 cells with 17D yellow fever virus: effects of chloroquine and cytochalasin B.

Brandriss MW, Schlesinger JJ.

J Gen Virol. 1984 Apr;65 ( Pt 4):791-4.PMID: 6707613 [PubMed - indexed for MEDLINE]Related articlesFree article

Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.

Walsh EE, Schlesinger JJ, Brandriss MW.

J Gen Virol. 1984 Apr;65 ( Pt 4):761-7.PMID: 6707612 [PubMed - indexed for MEDLINE]Related articlesFree article

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.

Walsh EE, Schlesinger JJ, Brandriss MW.

Infect Immun. 1984 Feb;43(2):756-8.PMID: 6363300 [PubMed - indexed for MEDLINE]Related articlesFree article

Facial pain mimicking transient ischemic attack: a case report.

Schlesinger JJ.

Spec Care Dentist. 1983 Nov-Dec;3(6):260-2. No abstract available. PMID: 6610222 [PubMed - indexed for MEDLINE]Related articles

17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor.

Schlesinger JJ, Brandriss MW.

J Gen Virol. 1983 Jun;64 (Pt 6):1255-62.PMID: 6854270 [PubMed - indexed for MEDLINE]Related articlesFree article

Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth.

Burstin SJ, Brandriss MW, Schlesinger JJ.

J Immunol. 1983 Jun;130(6):2915-9.PMID: 6304193 [PubMed - indexed for MEDLINE]Related articles

Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.

Monath TP, Kinney RM, Schlesinger JJ, Brandriss MW, Brès P.

J Gen Virol. 1983 Mar;64 Pt 3:627-37.PMID: 6298349 [PubMed - indexed for MEDLINE]Related articlesFree article